Nemaura Medical (NMRD)
(Delayed Data from OTC)
$0.00 USD
0.00 (42.86%)
Updated Oct 15, 2024 03:26 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Nemaura Medical, Inc falls in the month of March.
All items in Millions except Per Share data.
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 10 | 18 | 32 | 0 |
Receivables | NA | 0 | 0 | 0 | 0 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 2 | 1 | 1 | 0 |
Other Current Assets | NA | 1 | 1 | 1 | 0 |
Total Current Assets | NA | 14 | 20 | 34 | 1 |
Net Property & Equipment | NA | 1 | 1 | 0 | 0 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 1 | 1 | 0 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 15 | 22 | 35 | 1 |
Liabilities & Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Notes Payable | NA | 17 | 19 | 6 | 0 |
Accounts Payable | NA | 0 | 0 | 0 | 0 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 5 | 1 | 0 | 1 |
Total Current Liabilities | NA | 22 | 21 | 6 | 1 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 1 | 1 | 1 | 1 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 3 | 0 | 19 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 26 | 22 | 27 | 3 |
Shareholders Equity | 3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 41 | 38 | 32 | 17 |
Retained Earnings | NA | -52 | -38 | -24 | -18 |
Other Equity | NA | -1 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | -12 | 0 | 8 | -1 |
Total Liabilities & Shareholder's Equity | NA | 15 | 22 | 35 | 1 |
Total Common Equity | 0 | -12 | 0 | 8 | -1 |
Shares Outstanding | 40.30 | 28.90 | 24.10 | 22.90 | 20.80 |
Book Value Per Share | 0.00 | -0.41 | 0.02 | 0.37 | -0.06 |
Fiscal Year End for Nemaura Medical, Inc falls in the month of March.
All items in Millions except Per Share data.
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,999 | -99,999 | 0 | 4 |
Receivables | NA | NA | NA | 0 | 0 |
Notes Receivable | NA | NA | NA | 0 | 0 |
Inventories | NA | NA | NA | 4 | 3 |
Other Current Assets | NA | NA | NA | 0 | 0 |
Total Current Assets | NA | NA | NA | 4 | 8 |
Net Property & Equipment | NA | NA | NA | 1 | 1 |
Investments & Advances | NA | NA | NA | 0 | 0 |
Other Non-Current Assets | NA | NA | NA | 0 | 0 |
Deferred Charges | NA | NA | NA | 0 | 0 |
Intangibles | NA | NA | NA | 0 | 0 |
Deposits & Other Assets | NA | NA | NA | 0 | 0 |
Total Assets | NA | NA | NA | 5 | 9 |
Liabilities & Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | NA | 20 | 18 |
Accounts Payable | NA | NA | NA | 0 | 0 |
Current Portion Long-Term Debt | NA | NA | NA | 0 | 0 |
Current Portion Capital Leases | NA | NA | NA | 0 | 0 |
Accrued Expenses | NA | NA | NA | 0 | 0 |
Income Taxes Payable | NA | NA | NA | 0 | 0 |
Other Current Liabilities | NA | NA | NA | 3 | 3 |
Total Current Liabilities | NA | NA | NA | 23 | 21 |
Mortgages | NA | NA | NA | 0 | 0 |
Deferred Taxes/Income | NA | NA | NA | 0 | 0 |
Convertible Debt | NA | NA | NA | 0 | 0 |
Long-Term Debt | NA | NA | NA | 0 | 3 |
Non-Current Capital Leases | NA | NA | NA | 0 | 0 |
Other Non-Current Liabilities | NA | NA | 0 | 0 | |
Minority Interest (Liabilities) | NA | NA | NA | 0 | 0 |
Total Liabilities | NA | NA | NA | 23 | 25 |
Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | NA | 0 | 0 |
Common Stock (Par) | NA | NA | NA | 0 | 0 |
Capital Surplus | NA | NA | NA | 41 | 41 |
Retained Earnings | NA | NA | NA | -58 | -56 |
Other Equity | NA | NA | NA | -1 | -1 |
Treasury Stock | NA | NA | NA | 0 | 0 |
Total Shareholder's Equity | NA | NA | NA | -18 | -16 |
Total Liabilities & Shareholder's Equity | NA | NA | NA | 5 | 9 |
Total Common Equity | 0 | 0 | 0 | -18 | -16 |
Shares Outstanding | 40.30 | 40.30 | 40.30 | 28.90 | 28.90 |
Book Value Per Share | 0.00 | 0.00 | 0.00 | -0.62 | -0.55 |